By Thomas Anderson, Rotem Petranker — 2018
We just ran the first ever pre-registered scientific study on the microdosing of psychedelics and found some very promising results.
Read on theconversation.com
CLEAR ALL
The latest frontier in state and local drug reform has been the loosening of legal restrictions on psilocybin—the psychoactive compound in “magic mushrooms.”
Though psilocybin has recently become one of the trendiest drugs on the planet for the pharmaceutical industry to capitalize on, the history of magic mushrooms in human hands runs deep. How far back, you wonder? Perhaps the better question is: How long have we existed?
Before psychedelic therapy and services becomes widely available, there needs to be a better understanding of all the ways these experiences can go wrong.
Doctors who have been on the front lines of the pandemic since the first COVID cases appeared in the US now have the opportunity to try an unorthodox form of therapy: shrooms.
The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.
1
A single dose of psilocybin, a compound found in “magic mushrooms,” provides long-term relief of anxiety and depression in cancer patients, a new study finds.
3
The new research looked at cancer patients who took part in a study nearly five years ago.
Psychedelic drugs like psilocybin are being tested to treat mental illness. They're also expanding our understanding about human consciousness.
People of color are dealing with racism all the time, in large and small ways, and even dealing with racism in healthcare, even dealing with racism in therapy.
Two studies used psilocybin to see if the drug could reduce depression and anxiety in cancer patients. The results were striking.